Gene Therapy for Tendon Healing

Tendon Surgery of the Hand

Volumn , Issue , 2012, Pages 59-70

  Tang, Jin Bo ^a   Wu, Ya Fang ^a   Cao, Yi ^a   Chen, Chuan Hao ^b   Wang, Xiao Tian ^c   Liu, Paul Y ^c  

^a NANTONG UNIVERSITY   (China)

^b BENGBU MEDICAL COLLEGE   (China)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84877347140     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-2230-7.00006-X     Document Type: Chapter

References (50)

1. J Chang, R Thunder, D Most, et al. (2000) Studies in flexor tendon wound healing: neutralizing antibody to TGF-beta1 increases postoperative range of motion. Plast Reconstr Surg 105 148-155.
2. U Khan, S Kakar, A Akali, et al. (2000) Modulation of the formation of adhesions during the healing of injured tendons. J Bone Joint Surg (Br) 82 1054-1058.
3. J Lou, Y Tu, M Burns, et al. (2001) BMP-12 gene transfer augmentation of lacerated tendon repair. J Orthop Res 19 1199-1202.
4. Y Hamada, S Katoh, N Hibino, et al. (2006) Effects of monofilament nylon coated with basic fibroblast growth factor on endogenous intrasynovial flexor tendon healing. J Hand Surg (Am) 31 530-540.
5. JB Tang, Y Cao, B Zhu, et al. (2008) Adeno-associated virus-2-mediated bFGF gene transfer to digital flexor tendons significantly increases healing strength. An in vivo study. J Bone Joint Surg (Am) 90 1078-1089.
6. J Yao, T Korotkova, J Riboh, et al. (2008) Bioactive sutures for tendon repair: assessment of a method of delivering pluripotential embryonic cells. J Hand Surg (Am) 33 1558-1564.
7. S Thomopoulos, R Das, MJ Silva, et al. (2009) Enhanced flexor tendon healing through controlled delivery of PDGF-BB. J Orthop Res 27 1209-1215.
8. CH Chen, YL Zhou, YF Wu, et al. (2009) Effectiveness of microRNA in down-regulation of TGF-β gene expression in digital flexor tendons of chickens: in vitro and in vivo study. J Hand Surg (Am) 34 1777-1784.
9. SO Abrahamsson, G Lundborg and LS Lohmander (1991) Long-term explant culture of rabbit flexor tendon: effects of recombinant human insulin-like growth factor-I and serum on matrix metabolism. J Orthop Res 9 503-515.
10. SO Abrahamsson, G Lundborg and LS Lohmander (1991) Recombinant human insulin-like growth factor-I stimulates in vitro matrix synthesis and cell proliferation in rabbit flexor tendon. J Orthop Res 9 495-502.
11. RH Gelberman, D Amiel and F Harwood (1992) Genetic expression for type I procollagen in the early stages of flexor tendon healing. J Hand Surg (Am) 17 551-558.
12. FJ Duffy, JG Seiler, RH Gelberman, et al. (1995) Growth factors and canine flexor tendon healing: initial studies in uninjured and repair models. J Hand Surg (Am) 20 645-649.
13. J Chang, D Most, E Stelnicki, et al. (1997) Gene expression of transforming growth factor beta-1 in rabbit zone II flexor tendon wound healing: evidence for dual mechanisms of repair. Plast Reconstr Surg 100 937-944.
14. J Chang, D Most, R Thunder, et al. (1998) Molecular studies in flexor tendon wound healing: the role of basic fibroblast growth factor gene expression. J Hand Surg (Am) 23 1052-1058.
15. M Bidder, DA Towler, RH Gelberman, et al. (2000) Expression of mRNA for vascular endothelial growth factor at the repair site of healing canine flexor tendon. J Orthop Res 18 247-252.
16. MI Boyer, JT Watson, J Lou, et al. (2001) Quantitative variation in vascular endothelial growth factor mRNA expression during early flexor tendon healing: An investigation in a canine model. J Orthop Res 19 869-872.
17. T Tsubone, SL Moran, PC Amadio, et al. (2004) Expression of growth factors in canine flexor tendon after laceration in vivo. Ann Plast Surg 53 393-397.
18. V Mehta, Q Kang, J Luo, et al. (2005) Characterization of adenovirus-mediated gene transfer in rabbit flexor tendons. J Hand Surg (Am) 30 136-141.
19. V Mehta and D Mass (2005) The use of growth factors on tendon injuries. J Hand Ther 18 87-92.
20. S Thomopoulos, FL Harwood, MJ Silva, et al. (2005) Effect of several growth factors on canine flexor tendon fibroblast proliferation and collagen synthesis in vitro. J Hand Surg (Am) 30 441-447.
21. S Thomopoulos, R Das, S Sakiyama-Elbert, et al. (2010) bFGF and PDGF-BB for tendon repair: controlled release and biologic activity by tendon fibroblasts in vitro. Ann Biomed Eng 38 225-234.
22. SE Sakiyama-Elbert, R Das, RH Gelberman, et al. (2008) Controlled-release kinetics and biologic activity of platelet-derived growth factor-BB for use in flexor tendon repair. J Hand Surg (Am) 33 1548-1557.
23. JB Tang, Y Xu, F Ding, et al. (2003) Tendon healing in vitro: promotion of collagen gene expression by bFGF with NF-κB gene activation. J Hand Surg (Am) 28 215-220.
24. JB Tang, Y Xu, F Ding, et al. (2004) Expression of genes for collagen production and NF-κB gene activation of in vivo healing flexor tendons. J Hand Surg (Am) 29 564-570.
25. JB Tang, Y Xu and XT Wang (2004) Tendon healing in vitro: activation of NIK, IKKα, IKKβ, and NF-κB genes in signal pathway and proliferation of tenocytes. Plast Reconstr Surg 113 1703-1711.
26. B Zhu, Y Cao, KQ Xin, et al. (2006) Tissue reactions of adenoviral, adeno-associated viral, and liposome-plasmid vectors in tendons and comparison with early-stage healing responses of injured flexor tendons. J Hand Surg (Am) 31 1652-1660.
27. XT Wang, PY Liu, JB Tang, et al. (2007) Tendon healing in vitro: adeno-associated virus-2 effectively transduces intrasynovial tenocytes with persistent expression of the transgene, but other serotypes do not. Plast Reconstr Surg 119 227-234.
28. CH Chen, Y Cao, YF Wu, et al. (2008) Tendon healing in vivo: gene expression and production of multiple growth factors in early tendon healing period. J Hand Surg (Am) 33 1834-1842.
29. YF Wu, CH Chen, Y Cao, et al. (2010) Molecular events of cellular apoptosis and proliferation in the early tendon healing period. J Hand Surg (Am) 35 2-10.
30. CH Evans (2004) Orthopedics: gene therapy's dark horse. Gene Ther 11 343.
31. CH Evans, SC Ghivizzani and PD Robbins (2009) Progress and Prospects: genetic treatments for disorders of bones and joints. Gene Ther 16 944-952.
32. LK Branski, CT Pereira, DN Herndon, et al. (2007) Gene therapy in wound healing: present status and future directions. Gene Ther 14 1-10.
33. H Kubota, PR Manske, M Aoki, et al. (1996) Effect of motion and tension on injured flexor tendons in chickens. J Hand Surg (Am) 21 456-463.
34. H Hatanaka, J Zhang and PR Manske (2000) An in vivo study of locking and grasping techniques using a passive mobilization protocol in experimental animals. J Hand Surg (Am) 25 260-269.
35. MI Boyer, RH Gelberman, ME Burns, et al. (2001) Intrasynovial flexor tendon repair. An experimental study comparing low and high levels of in vivo force during rehabilitation in canines. J Bone Joint Surg (Am) 83 891-899.
36. T Friedmann and R Roblin (1972) Gene therapy for human genetic disease? Science 175 949-955.
37. JW Bainbridge, AJ Smith, SS Barker, et al. (2008) Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 358 2231-2239.
38. K Mancuso, WW Hauswirth, Q Li, et al. (2009) Gene therapy for red-green colour blindness in adult primates. Nature 461(7265), 784-787.
39. N Cartier, S Hacein-Bey-Abina, CC Bartholomae, et al. (2009) Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326(5954), 818-823.
40. AK Chong, AD Ang, JC Goh, et al. (2007) Bone marrow-derived mesenchymal stem cells influence early tendon-healing in a rabbit Achilles tendon model. J Bone Joint Surg (Am) 89 74-81.
41. BP Chan, S Fu, L Qin, et al. (2000) Effects of basic fibroblast growth factor (bFGF) on early stages of tendon healing: a rat patellar tendon model. Acta Orthop Scand 71 513-518.
42. RF Henn, CE Kuo, MW Kessler, et al. (2010) Augmentation of zone II flexor tendon repair using growth differentiation factor 5 in a rabbit model. J Hand Surg (Am) 35 1825-1832.
43. S Thomopoulos, HM Kim, R Das, et al. (2010) The effects of exogenous basic fibroblast growth factor on intrasynovial flexor tendon healing in a canine model. J Bone Joint Surg (Am) 92 2285-2293.
44. PE Monahan and RJ Samulski (2000) AAV vectors: is clinical success on the horizon? Gene Ther 7 24-30.
45. K Erles, P Sebökovà and JR Schlehofer (1999) Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV). J Med Virol 59 406-411.
46. TM Daly (2004) Overview of adeno-associated viral vectors. Methods Mol Biol 246 157-165.
47. C Mueller and TR Flotte (2008) Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther 15 858-863.
48. ML Aitken, RB Moss, DA Waltz, et al. (2001) A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Hum Gene Ther 12 1907-1916.
49. MG Kaplitt, A Feigin, C Tang, et al. (2007) Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 369(9579), 2097-2105.
50. XT Wang, PY Liu, KQ Xin, et al. (2005) Tendon healing in vitro: bFGF gene transfer to tenocytes by adeno-associated viral vectors promotes expression of collagen genes. J Hand Surg (Am) 30 1255-1261.